<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83294">
  <stage>Registered</stage>
  <submitdate>22/10/2008</submitdate>
  <approvaldate>30/01/2009</approvaldate>
  <actrnumber>ACTRN12609000073202</actrnumber>
  <trial_identification>
    <studytitle>Acupuncture treatment for menstrual disorder in women with Polycystic Ovarian Syndrome (PCOS)</studytitle>
    <scientifictitle>A randomised, single blinded, placebo controlled clinical trial of the effectiveness of Acupuncture in management of Polycystic Ovarian Syndrome  A multicentre trial</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Polycystic Ovarian Syndrome</healthcondition>
    <conditioncode>
      <conditioncode1>Reproductive Health and Childbirth</conditioncode1>
      <conditioncode2>Menstruation and menopause</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Body Acupuncture on selected body acupuncture points to be administered once a week for 12 weeks duration. Each acupuncture session lasts for 20 minutes. Principal acupuncture points used include R3, R4, EX-CA-18, SP6, ST 36.</interventions>
    <comparator>Sham Acupuncture - Acupuncture needle was not inserted at the treatment point. The needle will be placed at 0.5-1cm lateral to the real acupuncture point or use sham acupuncture needle holder. In either case, the acupuncture needle will not penetrate the skill. It will be administered once a week for 12 weeks duration. Each acupuncture session lasts for 20 minutes. Patients will not know whether they are receiving real or sham acupuncture throughout the study. However, women received sham acupuncture will be offered to received real acupuncture after the cessation of the study period.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Devices</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Return of Menstruation at the conclusion of the treatment period. It will be assessed by participating women's information while filling in the questionnaires. Patients will be followed up once a month for 3 months after treatment.</outcome>
      <timepoint>Once a month for 3 months throughout the duration of treatment. Each acupuncture session lasts for 20 minutes. Participating individuals will be followed up once a month for up to 3 months after the treatment is completed.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Improved Luteinizing Hormone : Follicle Stimulating Hormone Ratio
Reduce Androgenic hormone concentration. This will be evaluated by a series of blood tests throughout the study</outcome>
      <timepoint>Once at the beginning of the treatment and also once after the conclusion of treatment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Rottendam Consensus on PCOS: Any patient with the presence of 2 out of 3 criteria as listed below will be considered as having Polycystic Ovarian Syndrome:
1, Oligo/anovulation; 2, hyperandrogenaemia; 3, polycystic ovaries</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>45</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients with one or more of the following conditions will be excluded:
1, Other active ovarian, uterine or pelvic inflammatory diseases; 2, Major systemic diseases; 3, Pregnancy</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment />
    <designfeatures />
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>1/05/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>99</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>China</country>
      <state>GuangZhou</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Chinese Medicine Clinical Research Centre, Liverpool Hospital</primarysponsorname>
    <primarysponsoraddress>Chinese Medicine Clinical Research Centre, Liverpool Hospital, Elizabeth Street,
Liverpool, NSW 2170</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Hospital</sponsortype>
      <sponsorname>GuangDong Women and Children's Hospital, 13 Guang Yuan Xi Road, GuangZhou, GuangDong 510010</sponsorname>
      <sponsoraddress>13 Guang Yuan Xi Road, GuangZhou, GuangDong 510010</sponsoraddress>
      <sponsorcountry>China</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study is aimed to evaluate the role of acupuncture treatment for menstrual disorder in women with polycystic ovarian syndrome.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>University of New South Wales Human Ethics Committee</ethicname>
      <ethicaddress>High Street, Kensington, NSW 2052</ethicaddress>
      <ethicapprovaldate />
      <hrec>07289</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Danforn Lim</name>
      <address>Department of Obstetrics &amp; Gynaecology, 
Liverpool Hospital,
Elizabeth Street, Liverpool, NSW 2170</address>
      <phone>+61 2 98285630</phone>
      <fax />
      <email>celim@unswalumni.com</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Dr Danforn Lim</name>
      <address>Department of Obstetrics &amp; Gynaecology, 
Liverpool Hospital,
Elizabeth Street, Liverpool, NSW 2170</address>
      <phone>+61 2 98285630</phone>
      <fax />
      <email>celim@unswalumni.com</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Danforn Lim</name>
      <address>Department of Obstetrics &amp; Gynaecology, 
Liverpool Hospital,
Elizabeth Street, Liverpool, NSW 2170</address>
      <phone>+61 2 98285630</phone>
      <fax />
      <email>celim@unswalumni.com</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>